James B. Machamer

ORCID: 0000-0003-3532-8068
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurological disorders and treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Hereditary Neurological Disorders
  • Amyotrophic Lateral Sclerosis Research
  • Ion channel regulation and function
  • Neurobiology and Insect Physiology Research
  • Prion Diseases and Protein Misfolding
  • Traumatic Brain Injury Research
  • Insect and Pesticide Research
  • Microtubule and mitosis dynamics
  • RNA Research and Splicing
  • Insect Pest Control Strategies
  • TGF-β signaling in diseases
  • Genetics and Neurodevelopmental Disorders
  • Alzheimer's disease research and treatments
  • RNA modifications and cancer
  • Mitochondrial Function and Pathology
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Genetics, Aging, and Longevity in Model Organisms
  • Intracranial Aneurysms: Treatment and Complications
  • Healthcare and Venom Research
  • Developmental Biology and Gene Regulation
  • Protist diversity and phylogeny
  • Pesticide Exposure and Toxicity
  • Neurogenetic and Muscular Disorders Research

United States Army Medical Research Institute of Infectious Diseases
2017-2023

BASF (United States)
2023

Triangle
2023

Research Triangle Park Foundation
2023

United States Army
2016-2021

Johns Hopkins University
2012-2018

Johns Hopkins Medicine
2012-2018

University of Alabama at Birmingham
2012

University of Washington
1987-1993

Psychosocial outcome and recovery of a group 31 consecutive adult patients with moderate to severe head injuries were prospectively investigated over 2-year period. A friend control was used for comparison purposes. We conclude that have significant long-term impact on psychosocial functioning. More specifically, although there is an increase time in the number subjects who resume former levels activity, many severely head-injured people remain unable work, support themselves financially,...

10.3109/02699059309008165 article EN Brain Injury 1993-01-01

Pyridazine pyrazolecarboxamides (PPCs) are a novel insecticide class discovered and optimized at BASF. Dimpropyridaz is the first PPC to be submitted for registration controls many aphid species as well whiteflies other piercing-sucking insects.Dimpropyridaz tertiary amide PPCs proinsecticides that converted in vivo into secondary active forms by N-dealkylation. Active metabolites of potently inhibit function insect chordotonal neurons. Unlike Group 9 29 insecticides, which hyperactivate...

10.1002/ps.7352 article EN cc-by-nc-nd Pest Management Science 2023-01-09

Neuronal function depends on the retrograde relay of growth and survival signals from synaptic terminal, where neuron interacts with its targets, to nucleus, gene transcription is regulated. Activation Bone Morphogenetic Protein (BMP) pathway at Drosophila larval neuromuscular junction results in nuclear accumulation phosphorylated form factor Mad motoneuron nucleus. This turn regulates genes that control growth. How BMP signaling terminal relayed cell body nucleus regulate unknown. We show...

10.1242/jcs.094292 article EN Journal of Cell Science 2012-01-01

One hundred and two consecutive head injured patients were studied at 1 12 months after injury. Their performances compared with a group of uninjured friends. The results indicate that impairment in memory depends on the type task used, time from injury to testing, severity (that is, degree impaired consciousness). Head indices are more closely related behavioural outcome early as later At year, only those deep or prolonged consciousness (as represented by greater than day coma, Glasgow Coma...

10.1136/jnnp.50.12.1613 article EN Journal of Neurology Neurosurgery & Psychiatry 1987-12-01

Mutations in the RNA binding protein Fused sarcoma (FUS) are estimated to account for 5-10% of all inherited cases amyotrophic lateral sclerosis (ALS), but function FUS motor neurons is poorly understood.Here, we investigate early functional consequences overexpressing wild-type or ALS-associated mutant proteins Drosophila neurons, and compare them phenotypes arising from loss homolog FUS, Cabeza (Caz).We find that lethality locomotor correlate with levels transgene expression, indicating...

10.1093/hmg/ddu094 article EN Human Molecular Genetics 2014-02-25

Botulinum neurotoxins (BoNTs) are potent neuroparalytic toxins that cause mortality through respiratory paralysis. The approved medical countermeasure for BoNT poisoning is infusion of antitoxin immunoglobulins. However, antitoxins have poor therapeutic efficacy in symptomatic patients; thus, there an urgent need treatments reduce the artificial ventilation. We report US Food and Drug Administration-approved potassium channel blocker 3,4-diaminopyridine (3,4-DAP) reverses depression...

10.1172/jci.insight.132891 article EN cc-by JCI Insight 2020-01-29

Abstract Botulinum neurotoxins (BoNTs) are highly potent, select agent toxins that inhibit neurotransmitter release at motor nerve terminals, causing muscle paralysis and death by asphyxiation. Other than post-exposure prophylaxis with antitoxin, the only treatment option for symptomatic botulism is intubation supportive care until recovery, which can require weeks or longer. In previous studies, we reported FDA-approved drug 3,4-diaminopyridine (3,4-DAP) reverses early symptoms prolongs...

10.1186/s10020-022-00487-4 article EN cc-by Molecular Medicine 2022-06-03

Botulinum neurotoxins (BoNTs) are highly potent toxins that cleave neuronal SNARE proteins required for neurotransmission, causing flaccid paralysis and death by asphyxiation. Currently, there no clinical treatments to delay or reverse BoNT-induced blockade of neuromuscular transmission. While aminopyridines have demonstrated varying efficacy in transiently reducing following BoNT poisoning, the precise mechanisms which symptomatically treat botulism not understood. Here we found...

10.1038/s41598-017-16064-3 article EN cc-by Scientific Reports 2017-11-14

Introduction Botulinum neurotoxin (BoNT) causes neuroparalytic disease and death by blocking neuromuscular transmission. There are no specific therapies for clinical botulism the only treatment option is supportive care until function spontaneously recovers, which can take weeks or months after exposure. The highly specialized junction (NMJ) between phrenic motor neurons diaphragm muscle fibers main target of BoNT. Due to difficulty in eliciting respiratory paralysis without a high mortality...

10.3389/fncel.2023.1226194 article EN cc-by Frontiers in Cellular Neuroscience 2023-08-15
Coming Soon ...